Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Sees Significant Drop in Short Interest

Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) saw a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 14,600 shares, a decline of 57.4% from the October 31st total of 34,300 shares. Based on an average daily volume of 254,600 shares, the days-to-cover ratio is currently 0.1 days.

Chugai Pharmaceutical Price Performance

CHGCY stock opened at $22.00 on Friday. Chugai Pharmaceutical has a 52-week low of $14.52 and a 52-week high of $26.00. The business has a fifty day moving average of $23.21 and a two-hundred day moving average of $20.85.

About Chugai Pharmaceutical

Chugai Pharmaceutical Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company’s products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng.